Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods

BACKGROUND: Polyunsaturated fatty acid (PUFA) metabolism abnormalities have been long implicated in the etiology of schizophrenia. Although several randomized clinical trials have been carried out to assess the efficacy of omega-3 PUFA as add-on therapy in reducing psychopathology in populations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawełczyk, Tomasz, Grancow, Marta, Kotlicka-Antczak, Magdalena, Trafalska, Elżbieta, Gębski, Piotr, Szemraj, Janusz, Żurner, Natalia, Pawełczyk, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456694/
https://www.ncbi.nlm.nih.gov/pubmed/25934131
http://dx.doi.org/10.1186/s12888-015-0473-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456694/
https://www.ncbi.nlm.nih.gov/pubmed/25934131
http://dx.doi.org/10.1186/s12888-015-0473-2

Ejemplares similares